Matthew Angel is CEO & President +1 at Tempest Therapeutics, Inc. (TPST). They have made 1 open-market trade across 1 company since 2026, most recently 2026-03-24.
CIK 0001931356
1 open-market purchase totalling $500K since 2026, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| TPST | 231,482 | $151K |
Shares reported on the most recent Form 4, priced at the 2026-06-23 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TPST | BUY | 2026-03-24 | 2026-03-25 | $2.16 | $500K | -19.6% | -7.7% | -35.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.